[HTML][HTML] North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension

JR Boike, BG Thornburg, SK Asrani, MB Fallon… - Clinical …, 2022 - Elsevier
Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

Performance properties and applications of polytetrafluoroethylene (PTFE)—a review

E Dhanumalayan, GM Joshi - Advanced Composites and Hybrid Materials, 2018 - Springer
High-performance commodity polymers are in demand due to low cost, durability, easy
productivity, and recycling ability. This article comprises a survey on the performance …

EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis

P Angeli, M Bernardi, C Villanueva, C Francoz… - Journal of …, 2018 - Elsevier
The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

[HTML][HTML] Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites

C Bureau, D Thabut, F Oberti, S Dharancy, N Carbonell… - Gastroenterology, 2017 - Elsevier
Background & Aims There is controversy over the ability of transjugular intrahepatic
portosystemic shunts (TIPS) to increase survival times of patients with cirrhosis and …

Polytetrafluoroethylene: synthesis and characterization of the original extreme polymer

GJ Puts, P Crouse, BM Ameduri - Chemical reviews, 2019 - ACS Publications
This Review aims to be a comprehensive, authoritative, and critical review of general
interest to the chemistry community (both academia and industry) as it contains an extensive …

The use of rifaximin in the prevention of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled trial

C Bureau, D Thabut, C Jezequel… - Annals of internal …, 2021 - acpjournals.org
Background: The efficacy of rifaximin in the secondary prevention of overt hepatic
encephalopathy (HE) is well documented, but its effectiveness in preventing a first episode …

Fluorinated polymers as smart materials for advanced biomedical applications

VF Cardoso, DM Correia, C Ribeiro, MM Fernandes… - Polymers, 2018 - mdpi.com
Fluorinated polymers constitute a unique class of materials that exhibit a combination of
suitable properties for a wide range of applications, which mainly arise from their …

[HTML][HTML] Early use of TIPS in patients with cirrhosis and variceal bleeding

JC García-Pagán, K Caca, C Bureau… - … England Journal of …, 2010 - Mass Medical Soc
Background Patients with cirrhosis in Child–Pugh class C or those in class B who have
persistent bleeding at endoscopy are at high risk for treatment failure and a poor prognosis …

Portal hypertension and related complications: diagnosis and management

DA Simonetto, M Liu, PS Kamath - Mayo Clinic Proceedings, 2019 - Elsevier
Portal hypertension is a major complication of cirrhosis, and its consequences, including
ascites, esophageal varices, hepatic encephalopathy, and hepatorenal syndrome, lead to …

[HTML][HTML] Cirrhosis and its complications: evidence based treatment

S Nusrat, MS Khan, J Fazili… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Cirrhosis results from progressive fibrosis and is the final outcome of all chronic liver
disease. It is among the ten leading causes of death in United States. Cirrhosis can result in …